Archive March 17, 2016 Deciphera Pharmaceuticals to Present Data on its Highly-Selective Small Molecule CSF1R Immunokinase Inhibitor, DCC-3014, at American Association for Cancer Research Annual Meeting 2016
Archive March 9, 2016 Deciphera Pharmaceuticals to Present at American Chemical Society Annual Meeting
Archive February 29, 2016 Deciphera Pharmaceuticals to Present at Future Leaders in the Biotech Industry Conference
Archive January 5, 2016 Deciphera Pharmaceuticals Increases Size of Series B Financing to over $90 Million with Addition of SV Life Sciences
Archive December 1, 2015 Deciphera Pharmaceuticals to Present at Oppenheimer Annual Healthcare Conference
Archive November 23, 2015 Deciphera Pharmaceuticals to Present at Piper Jaffray Healthcare Conference
Archive September 21, 2015 Deciphera Pharmaceuticals Announces $75 Million Series B Financing to Advance Novel Oncology Pipeline
Archive August 18, 2015 Deciphera Pharmaceuticals Announces Study Results for Altiratinib Demonstrating Inhibition of Three Major Cancer-Promoting Pathways to Durably Block Tumor Growth and Invasion
Archive June 23, 2015 Top Medical Oncologists Join Deciphera Pharmaceuticals Scientific Advisory Board
Archive June 19, 2015 Deciphera Pharmaceuticals to Present at JMP Securities Life Sciences Conference
